Novartis Investigates Zolgensma Tumor Reports
Novartis has reported nine cases of tumors in children treated with its gene therapy Zolgensma. The FDA is currently investigating a potential link.
Results for “U.S. Food and Drug Administration (FDA)”
2 stories found.
Blood Pressure Medication Recall: What You Need to Know
A recall has been issued for specific lots of blood pressure medication due to quality concerns. Here is what patients should check.